{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:23:33Z","timestamp":1768476213242,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Sex, race, and ethnicity disparities in hypertension (HTN) treatment intensity have been previously described. It remains unclear if these disparities occur at treatment onset and whether they can be explained by differences in clinical factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a retrospective cross-sectional study of adults with newly treated HTN using linked EHR\u2005+\u2005claims data from OneFlorida\u2005+\u2005Consortium. We included Florida Medicaid &amp; Medicare-recipients diagnosed with HTN and prescribed\u2005\u2265\u20051 first-line antihypertensive during 2013\u20132020. We used generalized linear models to estimate differences in total therapeutic intensity score (TTIS)\u2013a patient\u2019s total daily dose (TDD) divided by recommended maximum TDD for a drug, summed across entire regimen\u2013by sex, race, and ethnicity. We then modeled the same, controlling for demographics, blood pressure, and relevant comorbidities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In total 4,094 patients (mean age 58\u2005\u00b1\u200516; female 57.6%; White 56.7%) were included. We observed variations in the initiation of antihypertensive classes by sex, race and ethnicity. In univariate analyses, men averaged 7.6% (95% CI: 3.9%\u201311.3%) greater TTIS versus women and Black individuals averaged 10.5% (95% CI: 6.6%\u201314.3%) greater TTIS versus White individuals, whereas no disparities were observed by ethnicity. After adjusting for clinical factors, these disparities persisted: men had 7.6% (95% CI: 3.9%\u201311.4%) greater TTIS versus women, and Black individuals had 17.9% (95% CI: 13.8%\u201321.9%) greater TTIS versus White individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>We observed disparities in treatment intensity by sex and race that were not explained by differences in clinical factors. There was sex-based variation in practice patterns, and Black individuals received more intensive initial antihypertensive therapy than White individuals.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaf060","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T01:21:59Z","timestamp":1745284919000},"page":"560-569","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-2511","authenticated-orcid":false,"given":"Shailina","family":"Keshwani","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla M","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-5961","authenticated-orcid":false,"given":"Almut G","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J","family":"Gurka","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, School of Medicine, University of Virginia , Charlottesville, Virginia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta G","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Libby","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, School of Medicine, University of Colorado Denver , Aurora, Colorado ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hogan","sequence":"additional","affiliation":[{"name":"Data Science Institute, Medical College of Wisconsin , Milwaukee, Wisconsin ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J","family":"Pepine","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda M","family":"Cooper-DeHoff","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]},{"name":"Center for Integrative Cardiovascular and Metabolic Disease, University of Florida , Gainesville, Florida ,","place":["USA"]},{"name":"Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-839X","authenticated-orcid":false,"given":"Steven M","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida ,","place":["USA"]},{"name":"Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida , Gainesville, Florida ,","place":["USA"]},{"name":"Center for Integrative Cardiovascular and Metabolic Disease, University of Florida , Gainesville, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025071501514074200_CIT0001","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/HYPERTENSIONAHA.122.19564","article-title":"hypertension 2022 update: focusing on the future","volume":"79","author":"Touyz","year":"2022","journal-title":"Hypertension"},{"key":"2025071501514074200_CIT0002","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/17512433.2023.2189585","article-title":"Sex and gender differences in the treatment of arterial hypertension","volume":"16","author":"Tamargo","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025071501514074200_CIT0003","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamacardio.2021.4996","article-title":"Association of differences in treatment intensification, missed visits, and scheduled follow-up interval with racial or ethnic disparities in blood pressure control","volume":"7","author":"Fontil","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025071501514074200_CIT0004","doi-asserted-by":"publisher","first-page":"e003166","DOI":"10.1161\/CIRCOUTCOMES.116.003166","article-title":"Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: the national health and nutrition examination survey, 2003 to 2012","volume":"10","author":"Gu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025071501514074200_CIT0005","doi-asserted-by":"publisher","first-page":"e13-e115","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2025071501514074200_CIT0006","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41371-023-00801-5","article-title":"Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care","volume":"37","author":"Bager","year":"2023","journal-title":"J Hum Hypertens"},{"key":"2025071501514074200_CIT0007","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.117.09801","article-title":"Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the united states, 1999 to 2014","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"key":"2025071501514074200_CIT0008","doi-asserted-by":"publisher","first-page":"e2249930","DOI":"10.1001\/jamanetworkopen.2022.49930","article-title":"Blood pressure control among black and white adults following a quality improvement program in a large integrated health system","volume":"6","author":"Harrison","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"2025071501514074200_CIT0009","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/jch.13089","article-title":"Disparities in hypertension and cardiovascular disease in blacks: the critical role of medication adherence","volume":"19","author":"Ferdinand","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501514074200_CIT0010","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"2025071501514074200_CIT0011","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Arch Intern Med"},{"key":"2025071501514074200_CIT0012","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0272-6386(12)80859-6","article-title":"Ethnicity and renal disease: lessons from the multiple risk factor intervention trial and the treatment of mild hypertension study","volume":"21","author":"Flack","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2025071501514074200_CIT0013","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1681\/ASN.2010101085","article-title":"Albuminuria and racial disparities in the risk for ESRD","volume":"22","author":"McClellan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025071501514074200_CIT0014","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2025071501514074200_CIT0015","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"2025071501514074200_CIT0016","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"2025071501514074200_CIT0017","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pcad.2016.09.004","article-title":"Hypertension treatment in blacks: discussion of the U.S. clinical practice guidelines","volume":"59","author":"Williams","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"2025071501514074200_CIT0018","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3122\/jabfm.2022.01.210276","article-title":"Differences in hypertension medication prescribing for black Americans and their association with hypertension outcomes","volume":"35","author":"Holt","year":"2022","journal-title":"J Am Board Fam Med"},{"key":"2025071501514074200_CIT0019","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ajh.2009.201","article-title":"Racial disparities in hypertension control, but not treatment intensification","volume":"23","author":"Umscheid","year":"2010","journal-title":"Am J Hypertens"},{"key":"2025071501514074200_CIT0020","doi-asserted-by":"publisher","first-page":"e026652","DOI":"10.1161\/JAHA.122.026652","article-title":"Initial antihypertensive regimens in newly treated patients: real world evidence from the OneFlorida+ clinical research network","volume":"12","author":"Smith","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025071501514074200_CIT0021","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jash.2016.10.005","article-title":"Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction","volume":"10","author":"Levy","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"2025071501514074200_CIT0022","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/HJH.0b013e3283619d6a","article-title":"Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)","volume":"31","author":"Dresser","year":"2013","journal-title":"J Hypertens"},{"key":"2025071501514074200_CIT0023","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0895-7061(96)00305-6","article-title":"A randomized study comparing a patient-directed hypertension management strategy with usual office-based care","volume":"10","author":"Zarnke","year":"1997","journal-title":"Am J Hypertens"},{"key":"2025071501514074200_CIT0024","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/jcm12030997","article-title":"The therapeutic intensity score as predictor of clinical outcomes after total and partial adrenalectomy for unilateral primary aldosteronism: results of a multicentric series","volume":"12","author":"Anceschi","year":"2023","journal-title":"J Clin Med"},{"key":"2025071501514074200_CIT0025","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.ajpc.2021.100230","article-title":"Age and sex disparities in hypertension control: the multi-ethnic study of atherosclerosis (MESA)","volume":"8","author":"Osude","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"2025071501514074200_CIT0026","doi-asserted-by":"publisher","first-page":"100632","DOI":"10.1016\/j.ajpc.2023.100632","article-title":"Age and sex disparities in blood pressure control and therapeutic inertia: impact of a quality improvement program","volume":"17","author":"Myers","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"2025071501514074200_CIT0027","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/aje\/kwz177","article-title":"Hypertension awareness, treatment, and control in US adults: trends in the hypertension control cascade by population subgroup (National Health and Nutrition Examination Survey, 1999-2016)","volume":"188","author":"Foti","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2025071501514074200_CIT0028","first-page":"1","article-title":"Hypertension prevalence and control among adults: United States, 2015-2016","volume":"289","author":"Fryar","year":"2017","journal-title":"NCHS Data Brief"},{"key":"2025071501514074200_CIT0029","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the united states, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"key":"2025071501514074200_CIT0030","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"Authors\/Task Force Members: 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"2025071501514074200_CIT0031","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","article-title":"The risk of hip fracture after initiating antihypertensive drugs in the elderly","volume":"172","author":"Butt","year":"2012","journal-title":"Arch Intern Med"},{"key":"2025071501514074200_CIT0032","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCOUTCOMES.115.002524","article-title":"Short-term risk of serious fall injuries in older adults initiating and intensifying treatment with antihypertensive medication","volume":"9","author":"Shimbo","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025071501514074200_CIT0033","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jamainternmed.2017.2924","article-title":"Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT","volume":"177","author":"Sexton","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025071501514074200_CIT0034","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","article-title":"Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025071501514074200_CIT0035","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (atherosclerosis risk in communities) study: JACC focus seminar 3\/8","volume":"77","author":"Wright","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf060\/62966584\/hpaf060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/8\/560\/62966584\/hpaf060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/8\/560\/62966584\/hpaf060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:51:51Z","timestamp":1752558711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/38\/8\/560\/8117232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf060","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,22]]}}}